CardioNet Announces Enhanced MCOT System
September 10 2009 - 9:32AM
Business Wire
CardioNet, Inc. (NASDAQ:BEAT) today announced the availability
of new, innovative clinical and reporting enhancements to the
Company’s existing Mobile Cardiac Outpatient Telemetry™ (MCOT™)
service. These enhancements allow physicians to access more in
depth data to better diagnose atrial fibrillation, heart pauses,
and ventricular tachycardia (a potentially dangerous fast
heartbeat).
“CardioNet remains dedicated to meeting the needs of
cardiologists and electrophysiologists and to delivering innovative
tools that allow these physicians to make more accurate diagnostic
decisions,” said Randy Thurman, CardioNet Chairman, President and
CEO. “The new enhancements sustain MCOT’s diagnostic and reporting
superiority in monitoring cardiac events.”
The new clinical indicators are important for monitoring
patients who are suffering from cardiac events, both symptomatic
and asymptomatic. These indicators become even more important when
used in combination with SomNet™, CardioNet’s program for
identifying a sleep disorder indicator. In the case of SomNet, a
more definitive diagnosis can be made as to the relationship of
arrhythmias to sleep disorders. With this latest enhancement to the
CardioNet MCOT service, doctors can see the frequency, time, and
duration of cardiac events within every 24 hours.
“The new reports made possible through these enhancements are
extremely relevant for treating patients,” said Dr. Peter Kowey,
CardioNet Medical Director, and Chief of the Division Of
Cardiovascular Disease for the Main Line Health System. “These
enhancements deepen our understanding of the individual cardiac
events for each patient and minimizes the likelihood of making an
inaccurate diagnosis and treatment decision.”
About CardioNet,
Inc.
CardioNet, Inc. is the leading provider of ambulatory,
continuous, real-time outpatient management solutions for
monitoring relevant and timely clinical information regarding an
individual's health. CardioNet's initial efforts are focused on the
diagnosis and monitoring of cardiac arrhythmias, or heart rhythm
disorders, with a solution that it markets as Mobile Cardiac
Outpatient Telemetry™ (MCOT™). More information can be found at
http://www.cardionet.com.
Forward Looking Statements
This press release includes certain forward-looking statements
within the meaning of the “Safe Harbor” provisions of the Private
Securities Litigation Reform Act of 1995 regarding, among other
things, our growth prospects, the prospects for our products and
our confidence in the Company’s future. These statements may be
identified by words such as “expect,” “anticipate,” “estimate,”
“intend,” “plan,” “believe,” “promises” and other words and terms
of similar meaning. Such forward-looking statements are based on
current expectations and involve inherent risks and uncertainties,
including important factors that could delay, divert, or change any
of them, and could cause actual outcomes and results to differ
materially from current expectations. These factors include, among
other things, the success of our sales and marketing initiatives,
our ability to attract and retain talented executive management and
sales personnel, our ability to identify acquisition candidates,
acquire them on attractive terms and integrate their operations
into our business, the commercialization of new products, market
factors, internal research and development initiatives, partnered
research and development initiatives, competitive product
development, changes in governmental regulations and legislation,
changes to reimbursement levels for our products, the continued
consolidation of payors, acceptance of our new products and
services and patent protection and litigation. For further details
and a discussion of these and other risks and uncertainties, please
see our public filings with the Securities and Exchange Commission,
including our latest periodic reports on Form 10-K and 10-Q. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events,
or otherwise.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024